Financials
- Market Capitalization 41.09 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.39
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 214 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 756.01 USD | -0.89% | +2.20% | -4.18% | +35.75% | 77.84 B USD | ||
| 313 | ARGX argenx SE - American Depositary Shares | 805.17 USD | -0.88% | -14.33% | -19.85% | +0.80% | 49.83 B USD | ||
| 448 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 223.90 USD | -1.37% | -2.21% | -10.50% | -51.55% | 29.96 B USD | ||
| 492 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.84 USD | -1.63% | +0.25% | -3.10% | +52.55% | 25.38 B USD |